Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MT-401 |
Synonyms | |
Therapy Description |
MT-401 are allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, which may target TAA-expressing tumor cells for cell killing (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MT-401 | MT401|MT 401|Zelenoleucel | MT-401 are allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, which may target TAA-expressing tumor cells for cell killing (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04511130 | Phase II | MT-401 | Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant | Active, not recruiting | USA | 0 |